Anthem (ANTM) PT Trimmed to $160 at UBS

November 3, 2016 8:21 AM EDT
Get Alerts ANTM Hot Sheet
Price: $150.63 +1.70%

Rating Summary:
    7 Buy, 6 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade ANTM Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

UBS analyst A.J. Rice reiterated a Buy rating and lowered his price target on Anthem (NYSE: ANTM) to $160.00 (from $162.00).

Rice commented, "Anthem expects its 2017 earnings to grow modestly versus its 2016 EPS outlook of "approximately" $10.80. In 2017, the company sees tailwinds to its earnings coming from a) Enrollment gains across Medicaid, Medicare (with Y/Y stable margins), selffunded businesses etc; b) Margin improvement in the individual ACA compliant and the Iowa Medicaid business; c) The impact of the one year HIF moratorium on the commercial biz; and d) potential capital deployment. 2017 headwinds include a) onetime SG&A cuts which benefited 2016 come back in 2017; b) enrollment and margin pressure due to a shift to ACA compliant offerings in the local group biz; and c) rate pressure in the Medicaid expansion business. Finally, Anthem is in the process of updating its LT growth plan and may revisit its 2018 EPS target of $14/share."

For an analyst ratings summary and ratings history on Anthem click here. For more ratings news on Anthem click here.

Shares of Anthem closed at $122.99 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS, Earnings

Add Your Comment